Is γ-glutamyl transferase activity a potential marker of left ventricular function during early postmyocardial

Amina Valjevac1, Alen Dzubur, Emina Nakas-Icindic

  • 1Department of Physiology, Faculty of Medicine, University of Sarajevo, Cekaluša 90, 71 000 Sarajevo, Bosnia & Herzegovina. amina.valjevac@mf.unsa.ba

Future Cardiology
|September 21, 2011
PubMed

Insights

Gamma-glutamyl transferase (GGT) levels increase after acute myocardial infarction (AMI) and correlate with cardiac dysfunction markers. This suggests GGT may predict left ventricular (LV) dilatation and dysfunction in early post-AMI patients.

Area of Science:

  • Cardiology
  • Biochemistry
  • Clinical Medicine

Background:

  • Gamma-glutamyl transferase (GGT) is a known prognostic marker for cardiac events in coronary artery disease.
  • Its role in the early stages following myocardial infarction (MI) remains less understood.

Purpose of the Study:

  • To investigate the clinical significance of GGT in the early post-acute myocardial infarction (AMI) period.
  • To explore the association between GGT and cardiac dysfunction, oxidative stress, and inflammatory markers.

Main Methods:

  • Prospective study of 40 AMI patients.
  • GGT activity, lipids, uric acid, homocysteine (Hcy), high-sensitivity C-reactive protein (hsCRP), and left ventricular (LV) function were measured on admission and day 5.
  • Statistical analysis included correlation and regression.

Main Results:

  • On admission, GGT correlated with Hcy, uric acid, and CK-MB.
  • GGT activity significantly increased by 77.7% post-AMI.
  • On day 5, GGT correlated with LV dimensions and function (relative wall thickness, end-diastolic diameter, fractional shortening), hsCRP, and Hcy.
  • LV end-diastolic diameter was independently associated with GGT on day 5.

Conclusions:

  • GGT levels are associated with oxidative/inflammatory markers and LV diastolic diameter post-AMI.
  • GGT may serve as a predictor of LV dilatation and dysfunction in the early phase after myocardial infarction.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...